Fenoldopam use in a burn intensive care unit: a retrospective study

BACKGROUND: Fenoldopam mesylate is a highly selective dopamine-1 receptor agonist approved for the treatment of hypertensive emergencies that may have a role at low doses in preserving renal function in those at high risk for or with acute kidney injury (AKI). There is no data on low-dose fenoldopam...

Descripción completa

Detalles Bibliográficos
Autores principales: Simmons, John W, Chung, Kevin K, Renz, Evan M, White, Christopher E, Cotant, Casey L, Tilley, Molly A, Hardin, Mark O, Jones, John A, Blackbourne, Lorne H, Wolf, Steven E
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904291/
https://www.ncbi.nlm.nih.gov/pubmed/20576149
http://dx.doi.org/10.1186/1471-2253-10-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2904291/
https://www.ncbi.nlm.nih.gov/pubmed/20576149
http://dx.doi.org/10.1186/1471-2253-10-9

Ejemplares similares